PE20010701A1 - Combinaciones oncoliticas para el tratamiento del cancer - Google Patents

Combinaciones oncoliticas para el tratamiento del cancer

Info

Publication number
PE20010701A1
PE20010701A1 PE2000001206A PE0012062000A PE20010701A1 PE 20010701 A1 PE20010701 A1 PE 20010701A1 PE 2000001206 A PE2000001206 A PE 2000001206A PE 0012062000 A PE0012062000 A PE 0012062000A PE 20010701 A1 PE20010701 A1 PE 20010701A1
Authority
PE
Peru
Prior art keywords
alkyl
cycloalkyl
cancer
carcinoma
treatment
Prior art date
Application number
PE2000001206A
Other languages
English (en)
Spanish (es)
Inventor
Edward C R Smith
Douglas Wade Beight
Jerome Herbert Fleisch
Beverly Ann Teicher
Jason Scott Sawyer
William Thomas Mcmillen
Roger Stuart Benjamin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20010701A1 publication Critical patent/PE20010701A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PE2000001206A 1999-11-11 2000-11-10 Combinaciones oncoliticas para el tratamiento del cancer PE20010701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
PE20010701A1 true PE20010701A1 (es) 2001-07-07

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001206A PE20010701A1 (es) 1999-11-11 2000-11-10 Combinaciones oncoliticas para el tratamiento del cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (xx)
JP (1) JP2003513916A (xx)
KR (1) KR20020069512A (xx)
CN (1) CN1390139A (xx)
AR (1) AR032432A1 (xx)
AU (1) AU778829B2 (xx)
BR (1) BR0015490A (xx)
CA (1) CA2391416A1 (xx)
CZ (1) CZ20021551A3 (xx)
EA (1) EA200200545A1 (xx)
HK (1) HK1050132A1 (xx)
HU (1) HUP0204449A3 (xx)
IL (1) IL148579A0 (xx)
MX (1) MXPA02004733A (xx)
NO (1) NO20022245L (xx)
NZ (1) NZ517667A (xx)
PE (1) PE20010701A1 (xx)
PL (1) PL355172A1 (xx)
SK (1) SK6492002A3 (xx)
TR (1) TR200201245T2 (xx)
WO (1) WO2001034137A2 (xx)
ZA (1) ZA200202822B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
JP2003532675A (ja) * 2000-05-09 2003-11-05 クレイトン ユニバーシティ 癌細胞の増殖を阻害しそのアポトーシスを誘導する方法
EP1311262A4 (en) 2000-07-28 2005-06-01 Cancer Rec Tech Ltd COMBINED TREATMENT AGAINST CANCER
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
ATE515494T1 (de) 2004-05-05 2011-07-15 High Point Pharmaceuticals Llc Neue verbindungen, deren herstellung und verwendung
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
US7943669B2 (en) 2005-06-30 2011-05-17 High Point Pharmaceuticals, Llc Phenoxy acetic acids as PPAR delta activators
EP1979311B1 (en) 2005-12-22 2012-06-13 High Point Pharmaceuticals, LLC Phenoxy acetic acids as ppar delta activators
CA2645719A1 (en) 2006-03-09 2007-09-13 High Point Pharmaceuticals, Llc Compounds that modulate ppar activity, their preparation and use
EP2080751A4 (en) 2006-10-12 2011-06-22 Inst Med Molecular Design Inc CARBOXYLIC ACID DERIVATIVE
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
WO2014067962A1 (de) 2012-10-31 2014-05-08 Bayer Cropscience Ag Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
SK6492002A3 (en) 2003-09-11
NO20022245L (no) 2002-07-09
NZ517667A (en) 2004-05-28
AR032432A1 (es) 2003-11-12
WO2001034137A2 (en) 2001-05-17
NO20022245D0 (no) 2002-05-10
HK1050132A1 (zh) 2003-06-13
MXPA02004733A (es) 2002-08-30
BR0015490A (pt) 2002-07-09
JP2003513916A (ja) 2003-04-15
CZ20021551A3 (cs) 2003-02-12
ZA200202822B (en) 2003-09-23
HUP0204449A2 (hu) 2003-04-28
EP1231938A2 (en) 2002-08-21
IL148579A0 (en) 2002-09-12
TR200201245T2 (tr) 2004-08-23
CN1390139A (zh) 2003-01-08
AU778829B2 (en) 2004-12-23
HUP0204449A3 (en) 2006-02-28
AU1599001A (en) 2001-06-06
CA2391416A1 (en) 2001-05-17
WO2001034137A3 (en) 2002-02-14
PL355172A1 (en) 2004-04-05
EA200200545A1 (ru) 2002-12-26
KR20020069512A (ko) 2002-09-04

Similar Documents

Publication Publication Date Title
PE20010701A1 (es) Combinaciones oncoliticas para el tratamiento del cancer
TR200103474T2 (tr) Bileşimlerin anti-bakteriyel madde olarak yeni kullanımları
PE20001483A1 (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos
SE9704404D0 (sv) New compounds
TR200000837A2 (tr) Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler.
PE20081448A1 (es) Inhibidores de transcriptasa inversa no nucleosidicos
PT1041072E (pt) Acidos dioxociclopentil hidroxamicos
PE20080706A1 (es) Arilmidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
PE20061303A1 (es) Composicion farmaceutica que comprende oxaprozina
TNSN07022A1 (fr) Derives de pyridine
ATE369845T1 (de) Behandlung der nebenwirkungen von statinen
CY1105160T1 (el) ΠΑΡΑΓΩΓΑ ΟΞΑΖΟΛΙΟΥ ΜΕ ΥΠΟΚΑΤΑΣΤΑΤΕΣ ΤΥΠΟΥ ΚΑΡΒΟΞΥΛΙΚΟΥ ΟΞΕΟΣ ΓΙΑ ΧΡΗΣΗ ΩΣ PPAR-α ΚΑΙ -γ ΕΝEPΓΟΠΟΙΗΤΕΣ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΔΙΑΒΗΤΗ
CY1111693T1 (el) Αντιιικοι παραγοντες
SE9801526D0 (sv) New compounds
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
TR200003383T2 (tr) HIV ve diğer virüs enfeksiyonlarının tedavisine yönelik bileşimler.
MY129310A (en) C-4 carbonate taxanes
SE9602286D0 (sv) New compounds
RU2000123169A (ru) Бензотиадиазолы и их производные
PE20001083A1 (es) Derivados de mononitrato de isosorbide
FR2819507B1 (fr) Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
JP2005526773A5 (xx)
ATE273277T1 (de) Piperidinyl- und n-amidinopiperidinyl-derivate
ATE340572T1 (de) Benzazole derivate zur behandlung von scleroderma
DE602005009839D1 (de) Alkyl-und piperidin-substitutierte benzimidazol-derivate

Legal Events

Date Code Title Description
FD Application declared void or lapsed